TPM
GILD icon

Triasima Portfolio Management’s Gilead Sciences GILD Stock Holding History

Triasima Portfolio Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.72M Sell
45,238
-2,874
-6% -$379K 0.77% 51
2026
Q1 		$6.71M Buy
48,112
+925
+2% +$130K 1.01% 31
2025
Q4 		$5.79M Buy
47,187
+8,076
+21% +$981K 0.87% 38
2025
Q3 		$4.34M Buy
39,111
+4,445
+13% +$505K 0.66% 50
2025
Q2 		$3.84M Buy
34,666
+30,971
+838% +$3.3M 0.7% 52
2025
Q1 		$414K Buy
+3,695
New +$381K 0.08% 124
2023
Q3 		– Sell
-6,850
Closed -$699K – 138
2023
Q2 		$699K Hold
6,850
– – 0.04% 106
2023
Q1 		$568K Buy
6,850
+3,485
+104% +$289K 0.05% 105
2022
Q4 		$289K Buy
+3,365
New +$266K 0.02% 115

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Triasima Portfolio Management's GILD Position: Q2 2026 in Review

Triasima Portfolio Management reduced its Gilead Sciences (GILD) stake by 6% in Q2 2026, selling an estimated $379K and leaving 45,238 shares worth $5.72M. The position accounts for 0.77% of the portfolio, ranked #51.

Triasima Portfolio Management first reported a position in GILD in Q4 2022 and has held it in 9 quarters since. The position peaked at $6.71M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Triasima Portfolio Management held 45,238 shares of Gilead Sciences worth $5.72M as of Q2 2026.
  • Triasima Portfolio Management sold 2,874 Gilead Sciences shares in Q2 2026, an estimated $379K.
  • Gilead Sciences made up 0.77% of Triasima Portfolio Management's portfolio in Q2 2026, its #51 holding.
  • Triasima Portfolio Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 9 quarters since.
  • Triasima Portfolio Management's Gilead Sciences position peaked at $6.71M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Triasima Portfolio Management's 13F filing for Q2 2026, filed 21 Jul 2026.